6Ckine/CCL21A, Mouse (sf9)

6Ckine/CCL21A Protein, Mouse (sf9) is a homeostatic lymphoid chemokine that contributes to the entry of T cells and dendritic cells into the lymphoid T-zone. It acts through chemokine receptors CCR7 and CXCR3 to promote fibrogenic and inflammatory cytokine production. 6Ckine/CCL21A Protein, Mouse (sf9) is a recombinant mouse 6Ckine/CCL21A (S24-G133) expressed by Sf9 insect cells[1].

Product Specifications

Product Name Alternative

6Ckine/CCL21A Protein, Mouse (sf9), Mouse, Sf9 insect cells

UNSPSC

12352202

Type

Recombinant Proteins

Assay Protocol

https://www.medchemexpress.com/cytokines/6ckine-ccl21-protein-mouse-sf9.html

Purity

97.30

Molecular Formula

18829 (Gene_ID) P84444 (S24-G133) (Accession)

Molecular Weight

Approximately 12.1 kDa

References & Citations

[1]Balsam Rizeq, et al. The Role of CCL21/CCR7 Chemokine Axis in Breast Cancer Progression. Cancers (Basel) . 2020 Apr 23;12 (4) :1036.|[2]Knut Biber, et al. Neuronal CCL21 up-regulates microglia P2X4 expression and initiates neuropathic pain development. EMBO J. 2011 May 4;30 (9) :1864-73.|[3]Michael Hirth, et al. CXCL10 and CCL21 Promote Migration of Pancreatic Cancer Cells Toward Sensory Neurons and Neural Remodeling in Tumors in Mice, Associated With Pain in Patients. Gastroenterology. 2020 Aug;159 (2) :665-681.e13.